An Exploratory Tumor Biopsy-driven Study to Understand the Relationship Between Biomarkers and Clinical Response in Melanoma Patients Receiving REGN2810 (Anti-PD-1)

Summary

This study is being conducted to compare the relationship of patient response to treatment to changes in tumor environment.

Timeline

Start

2017-04-10

Primary completion

2019-03-05

Completion

2020-03-19

Drugs

Indications